<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37438797</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1756-994X</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>12</Day></PubDate></JournalIssue><Title>Genome medicine</Title><ISOAbbreviation>Genome Med</ISOAbbreviation></Journal><ArticleTitle>Metagenomic assessment of gut microbial communities and risk of severe COVID-19.</ArticleTitle><Pagination><StartPage>49</StartPage><MedlinePgn>49</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">49</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13073-023-01202-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">The gut microbiome is a critical modulator of host immunity and is linked to the immune response to respiratory viral infections. However, few studies have gone beyond describing broad compositional alterations in severe COVID-19, defined as acute respiratory or other organ failure.</AbstractText><AbstractText Label="METHODS">We profiled 127 hospitalized patients with COVID-19 (n&#x2009;=&#x2009;79 with severe COVID-19 and 48 with moderate) who collectively provided 241 stool samples from April 2020 to May 2021 to identify links between COVID-19 severity and gut microbial taxa, their biochemical pathways, and stool metabolites.</AbstractText><AbstractText Label="RESULTS">Forty-eight species were associated with severe disease after accounting for antibiotic use, age, sex, and various comorbidities. These included significant in-hospital depletions of Fusicatenibacter saccharivorans and Roseburia hominis, each previously linked to post-acute COVID syndrome or "long COVID," suggesting these microbes may serve as early biomarkers for the eventual development of long COVID. A random forest classifier achieved excellent performance when tasked with classifying whether stool was obtained from patients with severe vs. moderate COVID-19, a finding that was externally validated in an independent cohort. Dedicated network analyses demonstrated fragile microbial ecology in severe disease, characterized by fracturing of clusters and reduced negative selection. We also observed shifts in predicted stool metabolite pools, implicating perturbed bile acid metabolism in severe disease.</AbstractText><AbstractText Label="CONCLUSIONS">Here, we show that the gut microbiome differentiates individuals with a more severe disease course after infection with COVID-19 and offer several tractable and biologically plausible mechanisms through which gut microbial communities may influence COVID-19 disease course. Further studies are needed to expand upon these observations to better leverage the gut microbiome as a potential biomarker for disease severity and as a target for therapeutic intervention.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Nguyen</LastName><ForeName>Long H</ForeName><Initials>LH</Initials><Identifier Source="ORCID">0000-0002-5436-4219</Identifier><AffiliationInfo><Affiliation>Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Chan Microbiome in Public Health Center, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Okin</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Drew</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Battista</LastName><ForeName>Vincent M</ForeName><Initials>VM</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jesudasen</LastName><ForeName>Sirus J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuntz</LastName><ForeName>Thomas M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Harvard Chan Microbiome in Public Health Center, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhosle</LastName><ForeName>Amrisha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Harvard Chan Microbiome in Public Health Center, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Kelsey N</ForeName><Initials>KN</Initials><AffiliationInfo><Affiliation>Harvard Chan Microbiome in Public Health Center, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinicke</LastName><ForeName>Trenton</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lo</LastName><ForeName>Chun-Han</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woo</LastName><ForeName>Jacqueline E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caraballo</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berra</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vieira</LastName><ForeName>Jacob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Ching-Ying</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Das Adhikari</LastName><ForeName>Upasana</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Ragon Institute of MGH, Harvard, and MIT, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Minsik</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sui</LastName><ForeName>Hui-Yu</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magicheva-Gupta</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McIver</LastName><ForeName>Lauren</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldberg</LastName><ForeName>Marcia B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Douglas S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Ragon Institute of MGH, Harvard, and MIT, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Disease, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huttenhower</LastName><ForeName>Curtis</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Harvard Chan Microbiome in Public Health Center, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chan</LastName><ForeName>Andrew T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. achan@mgh.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. achan@mgh.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Chan Microbiome in Public Health Center, Harvard T.H. Chan School of Public Health, Boston, MA, USA. achan@mgh.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA. achan@mgh.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lai</LastName><ForeName>Peggy S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. plai@mgh.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. plai@mgh.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K01 DK120742</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 DK125838</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002541</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HL116275</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Genome Med</MedlineTA><NlmUniqueID>101475844</NlmUniqueID><ISSNLinking>1756-994X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>Res Sq. 2022 Jun 07:rs.3.rs-1717624. doi: 10.21203/rs.3.rs-1717624/v1</RefSource><PMID Version="1">35677075</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064307" MajorTopicYN="Y">Microbiota</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054892" MajorTopicYN="N">Metagenome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Microbiome</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>14</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>13</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>12</Day><Hour>23</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37438797</ArticleId><ArticleId IdType="pmc">PMC10337137</ArticleId><ArticleId IdType="doi">10.1186/s13073-023-01202-6</ArticleId><ArticleId IdType="pii">10.1186/s13073-023-01202-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>COVID-19 map. Johns Hopkins Coronavirus Resource Center. Cited 2023 Apr 22. Available from: https://coronavirus.jhu.edu/map.html</Citation></Reference><Reference><Citation>Lynch SV, Pedersen O. The Human Intestinal Microbiome in Health and Disease. N Engl J Med. 2016;375:2369&#x2013;79. doi: 10.1056/NEJMra1600266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1600266</ArticleId><ArticleId IdType="pubmed">27974040</ArticleId></ArticleIdList></Reference><Reference><Citation>Keely S, Talley NJ, Hansbro PM. Pulmonary-intestinal cross-talk in mucosal inflammatory disease. Mucosal Immunol. 2012;5:7&#x2013;18. doi: 10.1038/mi.2011.55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2011.55</ArticleId><ArticleId IdType="pmc">PMC3243663</ArticleId><ArticleId IdType="pubmed">22089028</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordon Y. Antibiotics can impede flu vaccines. Nat. Rev. Immunol. 2019. 663. 10.1038/s41577-019-0227-3</Citation><ArticleIdList><ArticleId IdType="pubmed">31551570</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagan T, Cortese M, Rouphael N, Boudreau C, Linde C, Maddur MS, et al. Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans. Cell. 2019;178:1313&#x2013;1328.e13. doi: 10.1016/j.cell.2019.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.08.010</ArticleId><ArticleId IdType="pmc">PMC6750738</ArticleId><ArticleId IdType="pubmed">31491384</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C-J, Wu G-H, Kuo R-L, Shih S-R. Role of the intestinal microbiota in the immunomodulation of influenza virus infection. Microbes Infect. 2017;19:570&#x2013;9. doi: 10.1016/j.micinf.2017.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2017.09.002</ArticleId><ArticleId IdType="pubmed">28939355</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z, Wang H, Cui G, Lu H, Wang L, Luo H, et al. Alterations in the human oral and gut microbiomes and lipidomics in COVID-19. Gut. 2021;70:1253&#x2013;65. doi: 10.1136/gutjnl-2020-323826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323826</ArticleId><ArticleId IdType="pmc">PMC8042598</ArticleId><ArticleId IdType="pubmed">33789966</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Wan Y, Zuo T, Yeoh YK, Liu Q, Zhang L, et al. Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19. Gastroenterology. 2022;162:548&#x2013;561.e4. doi: 10.1053/j.gastro.2021.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.10.013</ArticleId><ArticleId IdType="pmc">PMC8529231</ArticleId><ArticleId IdType="pubmed">34687739</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, et al. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Gastroenterology. 2020;159:944&#x2013;955.e8. doi: 10.1053/j.gastro.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Liu Q, Zhang F, Lui GC-Y, Tso EY, Yeoh YK, et al. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut. 2021;70:276&#x2013;84. doi: 10.1136/gutjnl-2020-322294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-322294</ArticleId><ArticleId IdType="pmc">PMC7385744</ArticleId><ArticleId IdType="pubmed">32690600</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhan H, Zhang F, Liu Q, Tso EYK, Lui GCY, et al. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge. Gastroenterology. 2020;159:1302&#x2013;1310.e5. doi: 10.1053/j.gastro.2020.06.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.06.048</ArticleId><ArticleId IdType="pmc">PMC7318920</ArticleId><ArticleId IdType="pubmed">32598884</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng SC, Peng Y, Zhang L, Mok CK, Zhao S, Li A, et al. Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events. Gut. 2022; 10.1136/gutjnl-2021-326563</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8844967</ArticleId><ArticleId IdType="pubmed">35140064</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh YK, Zuo T, Lui GC-Y, Zhang F, Liu Q, Li AY, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698&#x2013;706. doi: 10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu S, Chen Y, Wu Z, Chen Y, Gao H, Lv L, et al. Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza. Clin Infect Dis. 2020;71:2669&#x2013;78. doi: 10.1093/cid/ciaa709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa709</ArticleId><ArticleId IdType="pmc">PMC7314193</ArticleId><ArticleId IdType="pubmed">32497191</ArticleId></ArticleIdList></Reference><Reference><Citation>Schult D, Reitmeier S, Koyumdzhieva P, Lahmer T, Middelhof M, Erber J, et al. Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19. Gut Microbes. 2022;14:2031840. doi: 10.1080/19490976.2022.2031840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2022.2031840</ArticleId><ArticleId IdType="pmc">PMC8855857</ArticleId><ArticleId IdType="pubmed">35174781</ArticleId></ArticleIdList></Reference><Reference><Citation>Nashed L, Mani J, Hazrati S, Stern DB, Subramanian P, Mattei L, et al. Gut microbiota changes are detected in asymptomatic very young children with SARS-CoV-2 infection. Gut. 2022; Available from: 10.1136/gutjnl-2021-326599</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9357857</ArticleId><ArticleId IdType="pubmed">35135843</ArticleId></ArticleIdList></Reference><Reference><Citation>Newsome RC, Gauthier J, Hernandez MC, Abraham GE, Robinson TO, Williams HB, et al. The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort. Gut Microbes. 2021;13:1&#x2013;15. doi: 10.1080/19490976.2021.1926840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2021.1926840</ArticleId><ArticleId IdType="pmc">PMC8205023</ArticleId><ArticleId IdType="pubmed">34100340</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Mak JWY, Su Q, Yeoh YK, Lui GC-Y, Ng SSS, et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71:544&#x2013;52. doi: 10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, Zhang W, Guo M, Xiao C, Fu Z, Yu S, et al. Integrated analysis of gut microbiome and host immune responses in COVID-19. Front Med. 2022;16:263&#x2013;75. doi: 10.1007/s11684-022-0921-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-022-0921-6</ArticleId><ArticleId IdType="pmc">PMC8902486</ArticleId><ArticleId IdType="pubmed">35258762</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinold J, Farahpour F, Fehring C, Dolff S, Konik M, Korth J, et al. A pro-inflammatory gut microbiome characterizes SARS-CoV-2 infected patients and a reduction in the connectivity of an anti-inflammatory bacterial network associates with severe COVID-19. Front Cell Infect Microbiol. 2021;11:747816. doi: 10.3389/fcimb.2021.747816.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.747816</ArticleId><ArticleId IdType="pmc">PMC8635721</ArticleId><ArticleId IdType="pubmed">34869058</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonhospitalized adults: Therapeutic management. COVID-19 Treatment Guidelines. Cited 2022 Apr 5. Available from: https://www.covid19treatmentguidelines.nih.gov/management/clinical-management/nonhospitalized-adults--therapeutic-management/</Citation></Reference><Reference><Citation>Zhou Y, Zhang J, Zhang D, Ma W-L, Wang X. Linking the gut microbiota to persistent symptoms in survivors of COVID-19 after discharge. J Microbiol. 2021;59:941&#x2013;8. doi: 10.1007/s12275-021-1206-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12275-021-1206-5</ArticleId><ArticleId IdType="pmc">PMC8356893</ArticleId><ArticleId IdType="pubmed">34382150</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med. 2020;383:2451&#x2013;60. doi: 10.1056/NEJMcp2009575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcp2009575</ArticleId><ArticleId IdType="pubmed">32412710</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol. 2004;57:1288&#x2013;94. doi: 10.1016/j.jclinepi.2004.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2004.03.012</ArticleId><ArticleId IdType="pubmed">15617955</ArticleId></ArticleIdList></Reference><Reference><Citation>Gall J-RL, Le Gall J-R. A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter Study. JAMA. 1993. 2957. 10.1001/jama.1993.03510240069035</Citation><ArticleIdList><ArticleId IdType="pubmed">8254858</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Moreno R, Takala J, Willatts S, De Mendon&#xe7;a A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707&#x2013;10. doi: 10.1007/BF01709751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01709751</ArticleId><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Sui H-Y, Weil AA, Nuwagira E, Qadri F, Ryan ET, Mezzari MP, et al. Impact of DNA Extraction Method on Variation in Human and Built Environment Microbial Community and Functional Profiles Assessed by Shotgun Metagenomics Sequencing. Front Microbiol. 2020;11:953. doi: 10.3389/fmicb.2020.00953.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.00953</ArticleId><ArticleId IdType="pmc">PMC7262970</ArticleId><ArticleId IdType="pubmed">32528434</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. Labs. Centers for Disease Control and Prevention. Cited 2020 Aug 20. Available from: https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-panel-primer-probes.html</Citation></Reference><Reference><Citation>McIver LJ, Abu-Ali G, Franzosa EA, Schwager R, Morgan XC, Waldron L, et al. bioBakery: a meta&#x2019;omic analysis environment. Bioinformatics. 2018;34:1235&#x2013;7. doi: 10.1093/bioinformatics/btx754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btx754</ArticleId><ArticleId IdType="pmc">PMC6030947</ArticleId><ArticleId IdType="pubmed">29194469</ArticleId></ArticleIdList></Reference><Reference><Citation>Beghini F, McIver LJ, Blanco-M&#xed;guez A, Dubois L, Asnicar F, Maharjan S, et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. Elife. 2021;10. 10.7554/eLife.65088</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8096432</ArticleId><ArticleId IdType="pubmed">33944776</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspi R, Altman T, Billington R, Dreher K, Foerster H, Fulcher CA, et al. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases. Nucleic Acids Res. 2014;42:D459&#x2013;71. doi: 10.1093/nar/gkt1103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt1103</ArticleId><ArticleId IdType="pmc">PMC3964957</ArticleId><ArticleId IdType="pubmed">24225315</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong J, Xia J. Computational Approaches for Integrative Analysis of the Metabolome and Microbiome. Metabolites. 2017;7. 10.3390/metabo7040062</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5746742</ArticleId><ArticleId IdType="pubmed">29156542</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallick H, Franzosa EA, Mclver LJ, Banerjee S, Sirota-Madi A, Kostic AD, et al. Predictive metabolomic profiling of microbial communities using amplicon or metagenomic sequences. Nat Commun. 2019;10:3136. doi: 10.1038/s41467-019-10927-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10927-1</ArticleId><ArticleId IdType="pmc">PMC6637180</ArticleId><ArticleId IdType="pubmed">31316056</ArticleId></ArticleIdList></Reference><Reference><Citation>Package &#x201c;vegan&#x201d;. 2022 Cited 2023 May 26. Available from: https://cran.r-project.org/web/packages/vegan/vegan.pdf</Citation></Reference><Reference><Citation>Wirbel J, Zych K, Essex M, Karcher N, Kartal E, Salazar G, et al. Microbiome meta-analysis and cross-disease comparison enabled by the SIAMCAT machine learning toolbox. Genome Biol. Springer Science and Business Media LLC; 2021;22:93. Available from: https://genomebiology.biomedcentral.com/articles/10.1186/s13059-021-02306-1</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8008609</ArticleId><ArticleId IdType="pubmed">33785070</ArticleId></ArticleIdList></Reference><Reference><Citation>Peschel S, M&#xfc;ller CL, von Mutius E, Boulesteix A-L, Depner M. NetCoMi: network construction and comparison for microbiome data in R. Brief Bioinform. 2021;22. 10.1093/bib/bbaa290</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8293835</ArticleId><ArticleId IdType="pubmed">33264391</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck DH, Smith GB, Pappachan JV, Millar B. External validation of the SAPS II, APACHE II and APACHE III prognostic models in South England: a multicentre study. Intensive Care Med. 2003;29:249&#x2013;56. doi: 10.1007/s00134-002-1607-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-002-1607-9</ArticleId><ArticleId IdType="pubmed">12536271</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira FL, Bota DP, Bross A, M&#xe9;lot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286:1754&#x2013;8. doi: 10.1001/jama.286.14.1754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.286.14.1754</ArticleId><ArticleId IdType="pubmed">11594901</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira-Silva S, Falony G, Darzi Y, Lima-Mendez G, Garcia Yunta R, Okuda S, et al. Species-function relationships shape ecological properties of the human gut microbiome. Nat Microbiol. 2016;1:16088. doi: 10.1038/nmicrobiol.2016.88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmicrobiol.2016.88</ArticleId><ArticleId IdType="pubmed">27573110</ArticleId></ArticleIdList></Reference><Reference><Citation>Das Adhikari U, Eng G, Farcasanu M, Avena LE, Choudhary MC, Triant VA, et al. Fecal severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) RNA is associated with decreased Coronavirus disease 2019 (COVID-19) survival. Clin Infect Dis. 2022;74:1081&#x2013;4. doi: 10.1093/cid/ciab623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab623</ArticleId><ArticleId IdType="pmc">PMC8406863</ArticleId><ArticleId IdType="pubmed">34245255</ArticleId></ArticleIdList></Reference><Reference><Citation>Rand WM. Objective Criteria for the Evaluation of Clustering Methods. J Am Stat Assoc. 1971;66:846&#x2013;50. doi: 10.1080/01621459.1971.10482356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01621459.1971.10482356</ArticleId></ArticleIdList></Reference><Reference><Citation>Qannari EM, Courcoux P, Faye P. Significance test of the adjusted Rand index. Application to the free sorting task. Food Qual Prefer. 2014;32:93&#x2013;7. doi: 10.1016/j.foodqual.2013.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodqual.2013.05.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Real R, Vargas JM. The Probabilistic Basis of Jaccard&#x2019;s Index of Similarity. Syst Biol. 1996;45:380&#x2013;5. doi: 10.1093/sysbio/45.3.380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sysbio/45.3.380</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen B, Yi X, Sun Y, Bi X, Du J, Zhang C, et al. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera. Cell. 2020;182:59&#x2013;72.e15. doi: 10.1016/j.cell.2020.05.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.032</ArticleId><ArticleId IdType="pmc">PMC7254001</ArticleId><ArticleId IdType="pubmed">32492406</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T, Stefanoni D, Reisz JA, Nemkov T, Bertolone L, Francis RO, et al. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight. 2020;5. 10.1172/jci.insight.140327</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7453907</ArticleId><ArticleId IdType="pubmed">32559180</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv L, Jiang H, Chen Y, Gu S, Xia J, Zhang H, et al. The faecal metabolome in COVID-19 patients is altered and associated with clinical features and gut microbes. Anal Chim Acta. 2021;1152:338267. doi: 10.1016/j.aca.2021.338267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aca.2021.338267</ArticleId><ArticleId IdType="pmc">PMC7847702</ArticleId><ArticleId IdType="pubmed">33648648</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo Marin B, Aghagoli G, Lavine K, Yang L, Siff EJ, Chiang SS, et al. Predictors of COVID-19 severity: A literature review. Rev Med Virol. 2021;31:1&#x2013;10. doi: 10.1002/rmv.2146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2146</ArticleId><ArticleId IdType="pmc">PMC7855377</ArticleId><ArticleId IdType="pubmed">32845042</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabaro S, D&#x2019;Esposito V, Di Matola T, Sale S, Cennamo M, Terracciano D, et al. Cytokine signature and COVID-19 prediction models in the two waves of pandemics. Sci Rep. 2021;11:20793. doi: 10.1038/s41598-021-00190-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-00190-0</ArticleId><ArticleId IdType="pmc">PMC8531346</ArticleId><ArticleId IdType="pubmed">34675240</ArticleId></ArticleIdList></Reference><Reference><Citation>Raschke RA, Agarwal S, Rangan P, Heise CW, Curry SC. Discriminant Accuracy of the SOFA Score for Determining the Probable Mortality of Patients With COVID-19 Pneumonia Requiring Mechanical Ventilation. JAMA. 2021;325:1469&#x2013;70. doi: 10.1001/jama.2021.1545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.1545</ArticleId><ArticleId IdType="pmc">PMC7890534</ArticleId><ArticleId IdType="pubmed">33595630</ArticleId></ArticleIdList></Reference><Reference><Citation>Peeling RW, Heymann DL, Teo Y-Y, Garcia PJ. Diagnostics for COVID-19: moving from pandemic response to control. Lancet. 2022;399:757&#x2013;68. doi: 10.1016/S0140-6736(21)02346-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02346-1</ArticleId><ArticleId IdType="pmc">PMC8687671</ArticleId><ArticleId IdType="pubmed">34942102</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen LH, Ma W, Wang DD, Cao Y, Mallick H, Gerbaba TK, et al. Association Between Sulfur-Metabolizing Bacterial Communities in Stool and Risk of Distal Colorectal Cancer in Men. Gastroenterology. 2020;158:1313&#x2013;25. doi: 10.1053/j.gastro.2019.12.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2019.12.029</ArticleId><ArticleId IdType="pmc">PMC7384232</ArticleId><ArticleId IdType="pubmed">31972239</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Nguyen LH, Mehta RS, Song M, Huttenhower C, Chan AT. Association between the sulfur microbial diet and risk of colorectal cancer. JAMA Netw Open. 2021;4:e2134308. doi: 10.1001/jamanetworkopen.2021.34308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.34308</ArticleId><ArticleId IdType="pmc">PMC8590167</ArticleId><ArticleId IdType="pubmed">34767023</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen LH, Cao Y, Hur J, Mehta RS, Sikavi DR, Wang Y, et al. The sulfur microbial diet is associated with increased risk of early-onset colorectal cancer precursors. Gastroenterology. 2021;161:1423&#x2013;1432.e4. doi: 10.1053/j.gastro.2021.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.07.008</ArticleId><ArticleId IdType="pmc">PMC8545755</ArticleId><ArticleId IdType="pubmed">34273347</ArticleId></ArticleIdList></Reference><Reference><Citation>Vacca M, Celano G, Calabrese FM, Portincasa P, Gobbetti M, De Angelis M. The Controversial Role of Human Gut Lachnospiraceae. Microorganisms. 2020. 573. 10.3390/microorganisms8040573</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7232163</ArticleId><ArticleId IdType="pubmed">32326636</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen ML, Takeda K, Sundrud MS. Emerging roles of bile acids in mucosal immunity and inflammation. Mucosal Immunol. 2019;12:851&#x2013;61. doi: 10.1038/s41385-019-0162-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-019-0162-4</ArticleId><ArticleId IdType="pubmed">30952999</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata Y, Fujii R, Hosoya M, Harada M, Yoshida H, Miwa M, et al. A G Protein-coupled Receptor Responsive to Bile Acids *. J Biol Chem. 2003;278:9435&#x2013;40. doi: 10.1074/jbc.M209706200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M209706200</ArticleId><ArticleId IdType="pubmed">12524422</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao H, Cao L, Jiang C, Che Y, Zhang S, Takahashi S, et al. Farnesoid X Receptor Regulation of the NLRP3 Inflammasome Underlies Cholestasis-Associated Sepsis. Cell Metab. 2017;25:856&#x2013;867.e5. doi: 10.1016/j.cmet.2017.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2017.03.007</ArticleId><ArticleId IdType="pmc">PMC6624427</ArticleId><ArticleId IdType="pubmed">28380377</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichinohe T, Pang IK, Kumamoto Y, Peaper DR, Ho JH, Murray TS, et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci U S A. 2011;108:5354&#x2013;9. doi: 10.1073/pnas.1019378108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1019378108</ArticleId><ArticleId IdType="pmc">PMC3069176</ArticleId><ArticleId IdType="pubmed">21402903</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefan KL, Kim MV, Iwasaki A, Kasper DL. Commensal Microbiota Modulation of Natural Resistance to Virus Infection. Cell. 2020;183:1312&#x2013;1324.e10. doi: 10.1016/j.cell.2020.10.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.047</ArticleId><ArticleId IdType="pmc">PMC7799371</ArticleId><ArticleId IdType="pubmed">33212011</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Chiang JYL. Nuclear receptors in bile acid metabolism. Drug Metab Rev. 2013;45:145&#x2013;55. doi: 10.3109/03602532.2012.740048.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/03602532.2012.740048</ArticleId><ArticleId IdType="pmc">PMC3676171</ArticleId><ArticleId IdType="pubmed">23330546</ArticleId></ArticleIdList></Reference><Reference><Citation>Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, et al. Vitamin D receptor as an intestinal bile acid sensor. Science. 2002;296:1313&#x2013;6. doi: 10.1126/science.1070477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1070477</ArticleId><ArticleId IdType="pubmed">12016314</ArticleId></ArticleIdList></Reference><Reference><Citation>Staudinger JL, Goodwin B, Jones SA, Hawkins-Brown D, MacKenzie KI, LaTour A, et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci U S A. 2001;98:3369&#x2013;74. doi: 10.1073/pnas.051551698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.051551698</ArticleId><ArticleId IdType="pmc">PMC30660</ArticleId><ArticleId IdType="pubmed">11248085</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu Z, Cervantes JL, Cicek BB, Mukherjee S, Venkatesh M, Maher LA, et al. Pregnane X Receptor Regulates Pathogen-Induced Inflammation and Host Defense against an Intracellular Bacterial Infection through Toll-like Receptor 4. Sci Rep. 2016;6:31936. doi: 10.1038/srep31936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep31936</ArticleId><ArticleId IdType="pmc">PMC4994038</ArticleId><ArticleId IdType="pubmed">27550658</ArticleId></ArticleIdList></Reference><Reference><Citation>Kongsbak M, Levring TB, Geisler C, von Essen MR. The vitamin d receptor and T cell function. Front Immunol. 2013;4:148. doi: 10.3389/fimmu.2013.00148.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2013.00148</ArticleId><ArticleId IdType="pmc">PMC3684798</ArticleId><ArticleId IdType="pubmed">23785369</ArticleId></ArticleIdList></Reference><Reference><Citation>Merino J, Joshi AD, Nguyen LH, Leeming ER, Mazidi M, Drew DA, et al. Diet quality and risk and severity of COVID-19: a prospective cohort study. Gut. 2021;70:2096&#x2013;104. doi: 10.1136/gutjnl-2021-325353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325353</ArticleId><ArticleId IdType="pmc">PMC8500931</ArticleId><ArticleId IdType="pubmed">34489306</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma W, Nguyen LH, Yue Y, Ding M, Drew DA, Wang K, et al. Associations between predicted vitamin D status, vitamin D intake, and risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) severity. Am J Clin Nutr. 2022;115:1123&#x2013;33. doi: 10.1093/ajcn/nqab389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/nqab389</ArticleId><ArticleId IdType="pmc">PMC8690242</ArticleId><ArticleId IdType="pubmed">34864844</ArticleId></ArticleIdList></Reference><Reference><Citation>Stutz MR, Dylla NP, Pearson SD, et al. Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failure. Nat Commun. 2022;13:6615. 10.1038/s41467-022-34260-2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9633022</ArticleId><ArticleId IdType="pubmed">36329015</ArticleId></ArticleIdList></Reference><Reference><Citation>Corum J, Zimmer C. Tracking Omicron and Other Coronavirus Variants. The New York Times. The New York Times; 2021; Cited 2022 Mar 16. Available from: https://www.nytimes.com/interactive/2021/health/coronavirus-variant-tracker.html</Citation></Reference><Reference><Citation>Nguyen LH, Okin D, Drew DA, Battista VM, Jesudasen S, Kuntz TM, et al. Metagenomic assessment of gut microbial communities and risk of severe COVID-19. PRJNA976404, NCBI Sequence Read Archive. Cited 2023 May 26. Available from: http://www.ncbi.nlm.nih.gov/bioproject/976404</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10337137</ArticleId><ArticleId IdType="pubmed">37438797</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>